TY - JOUR AU - Fadnes, Lars T. AU - Aas, Christer Frode AU - Vold, Jørn Henrik AU - Ohldieck, Christian AU - Leiva, Rafael Alexander AU - Chalabianloo, Fatemeh AU - Skurtveit, Svetlana AU - Lygren, Ole Jørgen AU - Dalgård, Olav AU - Vickerman, Peter AU - Midgard, Håvard AU - Løberg, Else-Marie AU - Johansson, Kjell Arne AU - Aas, Christer Frode AU - Buljovcic, Vibeke Bråthen AU - Chalabianloo, Fatemeh AU - Daltveit, Jan Tore AU - Alpers, Silvia Eiken AU - Fadnes, Lars T. AU - Eriksen, Trude Fondenes AU - Gundersen, Per AU - Hille, Velinda AU - Håberg, Kristin Holmelid AU - Johansson, Kjell Arne AU - Leiva, Rafael Alexander AU - Carlsen, Siv-Elin Leirvåg AU - Bonnier, Martine Lepsøy AU - Lorås, Lennart AU - Løberg, Else-Marie AU - Nordbotn, Mette Hegland AU - Nygård, Cathrine AU - Olsvold, Maria AU - Ohldieck, Christian AU - Sivertsen, Lillian AU - Torjussen, Hugo AU - Vold, Jørn-Henrik AU - Økland, Jan-Magnus AU - Eielsen, Tone Lise AU - Maldonado, Nancy Laura Ortega AU - Wilk, Ewa Joanna AU - Bjørnestad, Ronny AU - Lygren, Ole Jørgen AU - Pierron, Marianne Cook AU - Dalgard, Olav AU - Midgard, Håvard AU - Skurtveit, Svetlana AU - Vickerman, Peter AU - for the INTRO-HCV Study Group PY - 2019 DA - 2019/11/08 TI - Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV) JO - BMC Infectious Diseases SP - 943 VL - 19 IS - 1 AB - A large proportion of people who inject drugs (PWID) living with hepatitis C virus (HCV) infection have not been treated. It is unknown whether inclusion of HCV diagnostics and treatment into integrated substance use disorder treatment and care clinics will improve uptake and outcome of HCV treatment in PWID. The aim is to assess the efficacy of integrating HCV treatment to PWID and this paper will present the protocol for an ongoing trial. SN - 1471-2334 UR - https://doi.org/10.1186/s12879-019-4598-7 DO - 10.1186/s12879-019-4598-7 ID - Fadnes2019 ER -